Jingshan Bai
Research Subjects
Jingshan Bai has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Wenqiang Li
Department of Pulmonary and Critical Care Medicine, Zigong First People’s Hospital, Zigong, Sichuan, China
2 shared publications - Guojie Teng
Department of Respiratory Medicine, Xuanwu Hospital Capital Medical University, Beijing, China
1 shared publication - Qian Huang
Department of Respiratory Medicine, Dazhou Dachuan District People’s Hospital (Dazhou Third People’s Hospital), Dazhou, Sichuan, China
1 shared publication - Qian Huang
Dazhou Dachuan District People’s Hospital (Dazhou Third People’s Hospital), Sichuan, China
1 shared publication - Quan Yuan
Zigong First People’s Hospital, Sichuan, China
1 shared publication Yanlei Ge
Department of Respiratory Medicine, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, China
1 shared publication
Latest Publications
- Open Access
- 11 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (37) , e50633
Association of Life’s Crucial 9 with all-cause and cardiovascular mortality among the individuals with chronic inflammatory airway diseases
Patients with chronic inflammatory airway diseases (CIAD) have been found to carry a higher burden of cardiovascular diseases. The objective of our research is to explore the link between Life’s Crucial 9 (LC9), a newly introduced measure of cardiovascular health by the American Heart Association, and the risks of all-cause and cardiovascular mortality among patients with CIAD. This prospective cohort study included 2403 patients with CIAD who participated in the National Health and Nutrition Examination Survey from 2007 to 2018. Cox proportional hazards regression models were utilized to calculate the potential associations between LC9 and all-cause mortality and cardiovascular disease mortality in CIAD patients. Restricted cubic spline was employed to estimate possible nonlinear associations. A total of 2403 patients with CIAD were included in the study. The LC9 were divided into 4 quartiles, using the lowest quartile as the reference category for comparison. Following the adjustment for various confounding factors, it was observed that higher LC9 were linked to a reduced risk of all-cause and cardiovascular mortality among the patient population. After adjusting for age, sex, ethnicity, education level, marital status, poverty-to-income ratio, and insurance status, the risk of all-cause mortality decreased by 71% (hazard ratio = 0.29, 95% confidence interval: 0.18–0.49), and the risk of cardiovascular mortality decreased by 87% (hazard ratio = 0.13, 95% confidence interval: 0.05–0.35). Furthermore, the analysis utilizing restricted cubic splines uncovered a nonlinear, positive association between the LC9 scores and mortality rates, including all-cause and cardiovascular mortality, among patients with CIAD. This research indicates that elevated LC9 scores are linked to a lower likelihood of all-cause and cardiovascular mortality in individuals suffering from CIAD.
- 11 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (37) , e50633
Open AccessAssociation of Life’s Crucial 9 with all-cause and cardiovascular mortality among the individuals with chronic inflammatory airway diseases
Patients with chronic inflammatory airway diseases (CIAD) have been found to carry a higher burden of cardiovascular diseases. The objective of our research is to explore the link between Life’s Crucial 9 (LC9), a newly introduced measure of cardiovascular health by the American Heart Association, and the risks of all-cause and cardiovascular mortality among patients with CIAD. This prospective cohort study included 2403 patients with CIAD who participated in the National Health and Nutrition Examination Survey from 2007 to 2018. Cox proportional hazards regression models were utilized to calculate the potential associations between LC9 and all-cause mortality and cardiovascular disease mortality in CIAD patients. Restricted cubic spline was employed to estimate possible nonlinear associations. A total of 2403 patients with CIAD were included in the study. The LC9 were divided into 4 quartiles, using the lowest quartile as the reference category for comparison. Following the adjustment for various confounding factors, it was observed that higher LC9 were linked to a reduced risk of all-cause and cardiovascular mortality among the patient population. After adjusting for age, sex, ethnicity, education level, marital status, poverty-to-income ratio, and insurance status, the risk of all-cause mortality decreased by 71% (hazard ratio = 0.29, 95% confidence interval: 0.18–0.49), and the risk of cardiovascular mortality decreased by 87% (hazard ratio = 0.13, 95% confidence interval: 0.05–0.35). Furthermore, the analysis utilizing restricted cubic splines uncovered a nonlinear, positive association between the LC9 scores and mortality rates, including all-cause and cardiovascular mortality, among patients with CIAD. This research indicates that elevated LC9 scores are linked to a lower likelihood of all-cause and cardiovascular mortality in individuals suffering from CIAD.
- Open Access
- 24 April 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (17) , e48522
Mediating role of chronic inflammatory airway diseases in the association between volatile organic compounds exposure and depression
Depression is a prevalent mental disorder that imposes a substantial global burden, and environmental exposure has been increasingly implicated in its etiology. However, the specific mechanisms linking urinary exposure to volatile organic compounds (VOCs) with depression remain poorly understood. A potential association of VOCs with depression prevalence was explored in this study, which also assessed the mediating effect of chronic inflammatory airway diseases (CIAD). This study analyzed data from the National Health and Nutrition Examination Survey from 2011 to 2020, involving 1696 participants. An ultra-high-performance liquid chromatography–tandem mass spectrometry assay was employed to quantify the levels of 16 VOCs in urine samples. We employed weighted multivariable logistic regression models, coupled with mediation analysis, to assess the potential association between urinary concentrations of VOCs and the risk of depression, while also investigating the intermediary pathway involving CIAD. The diagnostic potential of urinary VOCs as biomarkers for depression was further assessed through receiver operating characteristic curve analysis. Screening of the 1696 study subjects indicated a depression prevalence of 11.4%. Notably, 4 urinary VOC metabolites demonstrated a statistically significant positive association with the disorder (odds ratio > 1, P < .05). The dose–response relationship between them was also statistically significant. Mediation analysis indicated that CIAD mediated 7.3% of the total effect of VOC exposure on depression ( P < .05). Contact with certain VOCs has been linked to an elevated incidence of depression disorder. CIAD plays a mediating role in the correlation between urinary VOCs and depression.
- 24 April 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (17) , e48522
Open AccessMediating role of chronic inflammatory airway diseases in the association between volatile organic compounds exposure and depression
Depression is a prevalent mental disorder that imposes a substantial global burden, and environmental exposure has been increasingly implicated in its etiology. However, the specific mechanisms linking urinary exposure to volatile organic compounds (VOCs) with depression remain poorly understood. A potential association of VOCs with depression prevalence was explored in this study, which also assessed the mediating effect of chronic inflammatory airway diseases (CIAD). This study analyzed data from the National Health and Nutrition Examination Survey from 2011 to 2020, involving 1696 participants. An ultra-high-performance liquid chromatography–tandem mass spectrometry assay was employed to quantify the levels of 16 VOCs in urine samples. We employed weighted multivariable logistic regression models, coupled with mediation analysis, to assess the potential association between urinary concentrations of VOCs and the risk of depression, while also investigating the intermediary pathway involving CIAD. The diagnostic potential of urinary VOCs as biomarkers for depression was further assessed through receiver operating characteristic curve analysis. Screening of the 1696 study subjects indicated a depression prevalence of 11.4%. Notably, 4 urinary VOC metabolites demonstrated a statistically significant positive association with the disorder (odds ratio > 1, P < .05). The dose–response relationship between them was also statistically significant. Mediation analysis indicated that CIAD mediated 7.3% of the total effect of VOC exposure on depression ( P < .05). Contact with certain VOCs has been linked to an elevated incidence of depression disorder. CIAD plays a mediating role in the correlation between urinary VOCs and depression.